# A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)

> **NCT06340490** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Guangdong Ruishun Biotech Co., Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** RJMty19 (CD19-CAR-DNT cells)

## Key facts

- **NCT ID:** NCT06340490
- **Lead sponsor:** Guangdong Ruishun Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-04-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340490, "A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06340490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*